Adipocytokine zinc α2 glycoprotein (ZAG) as a novel urinary biomarker for normo-albuminuric diabetic nephropathy

Diabetic Medicine

Volumn 29, Issue 7, 2012, Pages 945-949

  Lim, S C ^a   Liying, D Q ^a   Toy, W C ^a   Wong, M ^a   Yeoh, L Y ^a   Tan, C ^a,b   Lau, D ^a   Subramaniam, T ^a   Sum, C F ^a  

^a KHOO TECK PUAT HOSPITAL   (Singapore)

^b SCHOOL OF ENGINEERING   (Singapore)

Author keywords

Albuminuria; Biomarker; Diabetic nephropathy; Zinc 2 glycoprotein

Indexed keywords

ADIPOCYTOKINE; ALBUMIN; ALPHA 1 MICROGLOBULIN; CREATININE; GLYCOPROTEIN; UNCLASSIFIED DRUG; ZINC ALPHA 2 GLYCOPROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; FEMALE; GLOMERULAR DYSFUNCTION; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; WESTERN BLOTTING;

ADIPOKINES; ALBUMINURIA; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CARRIER PROTEINS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FLUORESCENCE; GLOMERULAR FILTRATION RATE; GLYCOPROTEINS; HUMANS; KIDNEY; MALE; MASS SPECTROMETRY; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 84862695545     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03564.x     Document Type: Article

References (16)

1. Thomas MC, Macisaac RJ, Jerums G, Weekes A, Moran J, Shaw JE et al. Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11). Diabetes Care 2009; 32: 1497-1502.
2. Araki S, Haneda M, Sugimoto T, Isono M, Isshiki K, Kashiwagi A et al. Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes 2005; 54: 2983-2987.
3. Hong CY, Hughes K, Chia KE, Ng V, Ling SL. Urinary α1-Microglobulin as a marker of nephropathy in Type 2 diabetic Asian subjects in Singapore. Diabetes Care 2003; 26: 338-342.
4. Otu HH, Can H, Spentzos D, Nelson RG, Hanson RL, Looker HC et al. Prediction of diabetic nephropathy using urine proteomic profiling 10years prior to development of nephropathy. Diabetes Care 2007; 30: 638-643.
5. Rao PV, Lu X, Standley M, Pattee P, Neelima G, Girisesh G et al. Proteomic identification of urinary biomarkers of diabetic nephropathy. Diabetes Care 2007; 30: 629-637.
6. Sharma K, Lee S, Han S, Lee S, Francos B, McCue P et al. Two-dimensional fluorescence difference gel electrophoresis analysis of the urine proteome in human diabetic nephropathy. Proteomics 2005; 5: 2648-2655.
7. Jiang H, Guan G, Zhang R, Liu G, Cheng J, Hou X, Cui Y. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy. Diabetes Metab Res Rev 2009; 25: 232-241.
8. Dihazi H, Müller GA, Lindner S, Meyer M, Asif AR, Oellerich M et al. Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients. Clin Chem 2007; 53: 1636-1645.
9. Jain S, Rajput A, Kumar Y, Uppuluri N, Arvind AS, Tatu U et al. Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder. J Assoc Physicians India 2005; 53: 513-520.
10. Hassan MI, Waheed A, Yadav S, Singh TP, Ahmad F. Zinc alpha 2-glycoprotein: a multidisciplinary protein. Mol Cancer Res 2008; 6: 892-906.
11. Selva DM, Lecube A, Hernández C, Baena JA, Fort JM, Simó R. Lower zinc-alpha2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance. J Clin Endocrinol Metab 2009; 94: 4499-4507.
12. Agrawal V, Shah A, Rice C, Franklin BA, McCullough PA. Impact of treating the metabolic syndrome on chronic kidney disease. Nat Rev Nephrol 2009; 5: 520-528.
13. Kitiyakara C, Yamwong S, Cheepudomwit S, Domrongkitchaiporn S, Unkurapinun N, Pakpeankitvatana V et al. The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort. Kidney Int 2007; 71: 693-700.
14. Varghese SA, Powell TB, Budisavljevic MN, Oates JC, Raymond JR, Almeida JS et al. Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol 2007; 18: 913-922.
15. Yagil C, Barak A, Ben-Dor D, Rosenmann E, Bernheim J, Rosner M et al. Nonproteinuric diabetes-associated nephropathy in the Cohen rat model of type 2 diabetes. Diabetes 2005; 54: 1487-1496.
16. Thongboonkerd V. Practical points in urinary proteomics. J Proteome Res 2007; 6: 3881-3890.